AURA
Price
$5.94
Change
-$0.09 (-1.49%)
Updated
Feb 3 closing price
Capitalization
377.21M
55 days until earnings call
Intraday BUY SELL Signals
IDYA
Price
$34.23
Change
+$7.44 (+27.77%)
Updated
Feb 3 closing price
Capitalization
3B
55 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AURA vs IDYA

Header iconAURA vs IDYA Comparison
Open Charts AURA vs IDYABanner chart's image
Aura Biosciences
Price$5.94
Change-$0.09 (-1.49%)
Volume$224.96K
Capitalization377.21M
IDEAYA Biosciences
Price$34.23
Change+$7.44 (+27.77%)
Volume$639.01K
Capitalization3B
AURA vs IDYA Comparison Chart in %
AURA
Daily Signal:
Gain/Loss:
IDYA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AURA vs. IDYA commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Buy and IDYA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (AURA: $5.94 vs. IDYA: $34.23)
Brand notoriety: AURA and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 122% vs. IDYA: 69%
Market capitalization -- AURA: $377.21M vs. IDYA: $3B
AURA [@Biotechnology] is valued at $377.21M. IDYA’s [@Biotechnology] market capitalization is $3B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 1 FA rating(s) are green whileIDYA’s FA Score has 1 green FA rating(s).

  • AURA’s FA Score: 1 green, 4 red.
  • IDYA’s FA Score: 1 green, 4 red.
According to our system of comparison, IDYA is a better buy in the long-term than AURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 5 TA indicator(s) are bullish while IDYA’s TA Score has 3 bullish TA indicator(s).

  • AURA’s TA Score: 5 bullish, 5 bearish.
  • IDYA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, AURA is a better buy in the short-term than IDYA.

Price Growth

AURA (@Biotechnology) experienced а +4.95% price change this week, while IDYA (@Biotechnology) price change was -1.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.22%. For the same industry, the average monthly price growth was +3.03%, and the average quarterly price growth was +35.17%.

Reported Earning Dates

AURA is expected to report earnings on Mar 31, 2026.

IDYA is expected to report earnings on Mar 31, 2026.

Industries' Descriptions

@Biotechnology (-4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($3B) has a higher market cap than AURA($377M). AURA YTD gains are higher at: 8.991 vs. IDYA (-0.984). AURA has higher annual earnings (EBITDA): -112.21M vs. IDYA (-204.84M). IDYA has more cash in the bank: 787M vs. AURA (162M). AURA has less debt than IDYA: AURA (17.8M) vs IDYA (27.2M). IDYA has higher revenues than AURA: IDYA (215M) vs AURA (0).
AURAIDYAAURA / IDYA
Capitalization377M3B13%
EBITDA-112.21M-204.84M55%
Gain YTD8.991-0.984-914%
P/E RatioN/AN/A-
Revenue0215M-
Total Cash162M787M21%
Total Debt17.8M27.2M65%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
63
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AURAIDYA
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
64%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
77%
Declines
ODDS (%)
Bearish Trend 10 days ago
83%
Bearish Trend 6 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signal:
Gain/Loss:
IDYA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFYCX14.600.16
+1.11%
Hartford Schroders Intl Multi-Cp Val C
VMMSX31.080.24
+0.78%
Vanguard Emerg Mkts Sel Stk Inv
BCREX14.990.07
+0.47%
BlackRock Real Estate Securities Inv C
OAYMX171.31-1.50
-0.87%
Oakmark Advisor
ETCEX12.97-0.32
-2.41%
Eventide Exponential Technologies C

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with NUVL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
+1.02%
NUVL - AURA
50%
Loosely correlated
+2.12%
DSGN - AURA
49%
Loosely correlated
-0.38%
IDYA - AURA
48%
Loosely correlated
+0.50%
XNCR - AURA
47%
Loosely correlated
-0.99%
SLDB - AURA
46%
Loosely correlated
+1.71%
More

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with NUVL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+0.50%
NUVL - IDYA
59%
Loosely correlated
+2.12%
OCUL - IDYA
57%
Loosely correlated
-6.99%
XENE - IDYA
56%
Loosely correlated
+1.62%
XNCR - IDYA
55%
Loosely correlated
-0.99%
BEAM - IDYA
54%
Loosely correlated
-0.11%
More